Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 2,820.40
-3.15 (-0.11%)
At close: Aug 21, 2026
Gland Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 67,253 | 64,307 | 56,165 | 56,647 | 36,246 | 44,007 |
Revenue Growth | 17.57% | 14.50% | -0.85% | 56.28% | -17.64% | 27.08% |
Gross Profit Gross Profit Growth | 39,785 | 37,972 | 31,544 | 31,108 | 17,651 | 21,513 |
Operating Income Operating Income Growth | 13,020 | 11,906 | 8,721 | 9,715 | 8,844 | 14,000 |
Net Income Net Income Growth | 11,288 | 10,273 | 6,985 | 7,725 | 7,810 | 12,117 |
Earnings Per Share EPS Growth | 68.41 | 62.28 | 42.40 | 46.89 | 47.43 | 73.64 |
EPS Growth | 46.34% | 46.89% | -9.58% | -1.14% | -35.59% | 16.91% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
USA USA Growth | 33,552 | 31,185 | 27,403 | 26,878 | 20,910 | 23,327 |
Europe Europe Growth | 14,762 | 14,110 | 10,225 | 10,528 | 1,871 | 2,398 |
India India Growth | 5,582 | 5,510 | 4,765 | 5,880 | 5,548 | 8,801 |
Rest of World (ROW) Rest of World (ROW) Growth | 11,230 | 11,169 | 11,377 | 11,817 | 6,893 | 8,481 |
Canada Canada Growth | - | 1,404 | 1,574 | 890.27 | 794.9 | 829.19 |
Australia Australia Growth | - | 851.32 | 742.94 | 626.45 | 218.24 | 170.87 |
New Zealand New Zealand Growth | - | 77.11 | 77.23 | 28.17 | 10.86 | - |
Total Total Growth | 67,254 | 64,307 | 56,165 | 56,647 | 36,246 | 44,007 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 33,591 | 33,591 | 29,522 | 19,388 | 37,628 | 32,457 |
Total Debt Total Debt Growth | 2,836 | 2,836 | 3,137 | 3,722 | 44.53 | 47.43 |
Net Cash (Debt) Net Cash Growth | 30,755 | 30,755 | 26,385 | 15,666 | 37,584 | 32,410 |
Net Cash Growth | 16.56% | 16.56% | 68.42% | -58.32% | 15.96% | 8.10% |
Net Cash Per Share Net Cash Per Share Growth | 186.40 | 186.45 | 160.15 | 95.10 | 228.22 | 196.97 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 10,314 | 9,147 | 9,968 | 3,640 | 7,908 |
Capital Expenditures CapEx Growth | - | -4,908 | -3,845 | -3,899 | -2,209 | -5,113 |
Free Cash Flow Free Cash Flow Growth | - | 5,406 | 5,302 | 6,069 | 1,430 | 2,794 |
Free Cash Flow Growth | - | 1.97% | -12.63% | 324.27% | -48.81% | -25.71% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 59.16% | 59.05% | 56.16% | 54.92% | 48.70% | 48.88% |
Operating Margin | 19.36% | 18.52% | 15.53% | 17.15% | 24.40% | 31.81% |
Pretax Margin | 23.59% | 22.77% | 18.92% | 19.99% | 29.10% | 36.78% |
Profit Margin | 16.78% | 15.97% | 12.44% | 13.64% | 21.55% | 27.53% |
FCF Margin | - | 8.41% | 9.44% | 10.71% | 3.95% | 6.35% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 20.000 | 20.000 | 18.000 | 20.000 |
Dividend Per Share Growth | 11.11% | 11.11% | -10.00% | - |
Dividend Yield | 0.71% | 1.19% | 1.15% | 1.12% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 41.20 | 27.20 | 37.56 | 39.35 | 26.74 | 44.38 |
P/FCF Ratio | 86.03 | 51.69 | 49.48 | 50.08 | 146.03 | 192.42 |
PS Ratio | 6.92 | 4.35 | 4.67 | 5.37 | 5.76 | 12.22 |